transcon ascendis：TransCon CNP
TransCon CNP
Technology
https://ascendispharma.com
TransCon is an innovative technology platform for drug development. It combines known biology with the benefits of prodrug and sustained-release technologies to ...
TransCon PTH
https://ascendispharma.com
TransCon PTH, an investigational long-acting prodrug of parathyroid hormone (PTH) designed to restore physiologic levels of PTH 24 hours a day.
Oncology
https://ascendispharma.com
Our TransCon technologies – sustained systemic release and sustained localized (intratumoral) release – may advance treatment of cancer. Hear from our ...
Technology
https://ascendispharma.us
TransCon is a powerful, flexible technology platform using advanced chemistry to develop new therapeutics addressing unmet patient needs in unprecedented ...
One
https://investors.ascendisphar
COPENHAGEN, Denmark , June 17, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today reported one-year (Week 52) data from its ...
Ascendis Pharma
https://ascendispharma.com
We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, ...
Pipeline
https://ascendispharma.com
Our diverse pipeline, based on our TransCon technologies, is designed to make a meaningful difference for patients with endocrinology rare diseases and ...
Ascendis Pharma Presents TransCon™ PTH ...
https://investors.ascendisphar
TransCon PTH (palopegteriparatide) is an investigational prodrug with sustained release of active parathyroid hormone (PTH [1-34]) administered ...